Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase
about
Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicansNew Insight on the Role of Plasminogen Receptor in Cancer ProgressionSurface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic targetThe urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodelingHistone H2B as a functionally important plasminogen receptor on macrophagesRequirement of plasminogen binding to its cell-surface receptor α-enolase for efficient regeneration of normal and dystrophic skeletal muscleBovine neonatal pancytopenia--comparative proteomic characterization of two BVD vaccines and the producer cell surface proteome (MDBK).Estrogen promotes prostate cancer cell migration via paracrine release of ENO1 from stromal cells.Pancreatic ductal adenocarcinoma: a review of immunologic aspects.Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination.The Anti-inflammatory Effect of GV1001 Mediated by the Downregulation of ENO1-induced Pro-inflammatory Cytokine Production.Neuron specific enolase: a promising therapeutic target in acute spinal cord injury.Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.Identification of regulatory Hck and PAI-2 proteins in the monocyte response to PEG-containing matrices.α-Enolase: a promising therapeutic and diagnostic tumor target.α-Enolase, a multifunctional protein: its role on pathophysiological situationsThree are better than one: plasminogen receptors as cancer theranostic targets.An evolutionary perspective on protein moonlighting.Serum level of anti-α-enolase antibody in untreated systemic lupus erythematosus patients correlates with 24-hour urine protein and D-dimer.Proteomic analysis of rosiglitazone and guggulsterone treated 3T3-L1 preadipocytes.Streptococcus sanguinis and the sera of patients with Behçet's disease stimulate membrane expression of α-enolase in human dermal microvascular endothelial cells.Characterization of plasminogen binding to NB4 promyelocytic cells using monoclonal antibodies against receptor-induced binding sites in cell-bound plasminogen.Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro.Sudden retinal vein thrombosis in a patient with nephrotic syndrome.Enolase-like protein present on the outer membrane of Pseudomonas aeruginosa binds plasminogen.Molecular characterisation and expression profiling of the ENO1 gene in the ovarian follicle of the Sichuan white goose.Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils.Enolase of Streptococcus Suis Serotype 2 Enhances Blood-Brain Barrier Permeability by Inducing IL-8 Release.Early quantitative profiling of differential retinal protein expression in lens-induced myopia in guinea pig using fluorescence difference two-dimensional gel electrophoresis.Crystal structure of enolase from Drosophila melanogaster.Detection of sperm-reactive antibodies in wild sika deer and identification of the sperm antigens.Proteomic identification of sperm antigens using serum samples from individuals with and without antisperm antibodies.Proteomic and transcriptomic analyses of macrophages with an increased resistance to oxidized low density lipoprotein (oxLDL)-induced cytotoxicity generated by chronic exposure to oxLDL.Progress in the biological function of alpha-enolase.Experimental and bioinformatic approach to identifying antigenic epitopes in human α- and β-enolases.
P2860
Q21090509-3CBB5CFF-44C8-4553-85DA-76B37AFC1F94Q26798032-AD400150-2444-49A2-8BE5-D5630D272161Q27311163-2942A213-34B5-45BF-A2A0-94DEE02142B7Q28257803-A7772DB4-4326-4DB5-A1D2-F8831E3F91D1Q28513058-C6E0A4A2-477F-4BED-BFBA-AD18E3F16C4DQ31109034-C7A96D5C-E861-4C40-B984-5478B093CE4FQ33405446-FCAC5865-32EB-4C22-BB0E-407EE5CE33FEQ33636309-818E851E-818E-4571-974A-867132487052Q35870682-045D859B-C34F-47F9-95EA-904A0C195410Q36337574-92930A69-7B3B-4AEE-B2A3-78B8A78E7A64Q36427736-8D3E06B5-6DA8-4EFF-A8DD-75B232C7C720Q36892833-4ADC78ED-2452-4110-846B-1174D31907DAQ36976473-4CF99BC6-041E-4D0B-8D12-464CEE03BC1FQ37414643-1EE06CC3-9D5D-4B56-B1BA-16BDFDF0C982Q37831975-03A08344-6EB0-43C9-BE43-A6C2ADE582C9Q38057216-3417C917-8BB8-44B9-A0CC-19219DD8F043Q38099731-928345CE-5861-4B2F-A97E-44C9679C3EECQ38268469-62551274-F5DB-4DBD-82F6-BC80873D7B94Q38669648-3D371F46-7D47-4C5F-ABD1-A719D40B3BD6Q39218842-70AE0567-0B8E-49A3-AF14-34542031F703Q39248668-81AB4154-BA75-4221-9EFC-1C6D3857B129Q39250578-1532FE2F-BF15-47AD-AB24-1685AC62390BQ40112496-8B5A1054-2012-4795-8C87-343C51CB3627Q41852144-0B1092AA-4F10-47A0-83AE-4FD61D5D091CQ42035609-7F721C9D-6E71-44AF-838D-C19C8D276BCFQ44587907-7E0A0992-DD5D-4331-B8FF-746BDE30B150Q44760466-8563C5D3-229C-45CB-9B2B-923853BAC414Q49049234-3089BD12-F174-45DA-9882-F338E8F8C1CBQ50047695-3564B569-1DFE-41E9-8D0F-BF1D0ECE21BBQ50935633-CADE4C3E-4E5F-472A-A417-6A87597F58E0Q52649224-E3F28984-6074-4CFE-821F-616282FAAD36Q52895901-2BF52D84-8A58-414F-87AE-D6D49E122C94Q53851433-CAB1A626-AE24-4FF5-BF9C-E521887920D5Q54209838-1FCC1362-1871-467D-ADEE-7FF88837EFB4Q55167243-74C9CA9E-7C28-4282-9EF1-E7CDF198ADD7
P2860
Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase
description
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im April 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel (gepubliceerd op 2003/04/01)
@nl
наукова стаття, опублікована у квітні 2003
@uk
مقالة علمية (نشرت في أبريل 2003)
@ar
name
Inhibition of cell surface med ...... antibody against alpha-Enolase
@ast
Inhibition of cell surface med ...... antibody against alpha-Enolase
@en
type
label
Inhibition of cell surface med ...... antibody against alpha-Enolase
@ast
Inhibition of cell surface med ...... antibody against alpha-Enolase
@en
prefLabel
Inhibition of cell surface med ...... antibody against alpha-Enolase
@ast
Inhibition of cell surface med ...... antibody against alpha-Enolase
@en
P2093
P2860
P921
P356
P1476
Inhibition of cell surface med ...... antibody against alpha-Enolase
@en
P2093
Elizabeth Merton
Jordi Félez
Lindsey A. Miles
Massoud Mirshahi
Merce Jardí
Pere Fábregas
Roser López-Alemany
Stephen Hawley
P2860
P304
P356
10.1002/AJH.10299
P577
2003-04-01T00:00:00Z